Key Drivers
- Margin Compression
- Rising Leverage
- Strong Liquidity
AIAI Summary
TMDX remains a compelling growth story, but investors should now demand proof that its logistics and international investments can convert 20%+ revenue growth into recovering margins and free cash flow before adding exposure, as rising leverage and a heavier cost base raise the downside if utilization lags.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Compression
- •Rising Leverage
- •Strong Liquidity
TMDX maintains strong liquidity and resilient gross margins, but investors should monitor sharp quarterly margin compression, rising leverage, weaker cash generation, and negative retained earnings.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support test
- •Weak momentum
TMDX remains in a modest last-month downtrend below $88–$90 resistance, with $82–$84 support critical for limiting further downside.
Rebounded after falling to $82.18 on 2026-09-11
Sentiment & News
Key News Insights:
- •Revenue Growth
- •Margin Pressure
- •Legal Scrutiny
TransMedics shows strong growth momentum and investor interest, but margin pressure, CFO transition, and legal investigations raise execution and risk concerns.
Near-term sentiment may remain constructive, though profitability and legal developments could increase volatility
Similar Companies in Healthcare
Other companies in the same sector with AI ratings